KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Petmed Express (PETS) Gains from Sales and Divestitures (2018 - 2022)

Historic Gains from Sales and Divestitures for Petmed Express (PETS) over the last 6 years, with Q1 2022 value amounting to $99000.0.

  • Petmed Express' Gains from Sales and Divestitures fell 2142.86% to $99000.0 in Q1 2022 from the same period last year, while for Mar 2022 it was $99000.0, marking a year-over-year decrease of 2142.86%. This contributed to the annual value of $99000.0 for FY2022, which is 2142.86% down from last year.
  • Latest data reveals that Petmed Express reported Gains from Sales and Divestitures of $99000.0 as of Q1 2022, which was down 2142.86% from $126000.0 recorded in Q1 2021.
  • In the past 5 years, Petmed Express' Gains from Sales and Divestitures registered a high of $126000.0 during Q1 2021, and its lowest value of $114.0 during Q1 2018.
  • Over the past 5 years, Petmed Express' median Gains from Sales and Divestitures value was $99000.0 (recorded in 2022), while the average stood at $82822.8.
  • Per our database at Business Quant, Petmed Express' Gains from Sales and Divestitures surged by 10165438.6% in 2019 and then tumbled by 3706.9% in 2020.
  • Quarter analysis of 5 years shows Petmed Express' Gains from Sales and Divestitures stood at $114.0 in 2018, then skyrocketed by 101654.39% to $116000.0 in 2019, then crashed by 37.07% to $73000.0 in 2020, then skyrocketed by 72.6% to $126000.0 in 2021, then fell by 21.43% to $99000.0 in 2022.
  • Its last three reported values are $99000.0 in Q1 2022, $126000.0 for Q1 2021, and $73000.0 during Q1 2020.